tm
Seeing Is Believing
tm
Seeing Is Believing
NMRD is currently covered by 2 analysts
Nemaura Medical's activity chart (see below) currently has 1 price targets and 6 ratings on display. The stock rating distribution of NMRD is 100% BUY.
Highest price target for NMRD is $4, Lowest price target is $1.
Most recent stock forecast was given by YI CHEN from HC WAINWRIGHT on 21-Aug-2023. First documented stock forecast 03-Dec-2021.
Currently out of the existing stock ratings of NMRD, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$2.5
$2.4 (2400.00%)
3 years 25 days ago
(21-Aug-2023)
0/3 (0%)
$1.74 (228.95%)
Buy
$4
$3.9 (3900.00%)
$7.5
3 years 1 months 29 days ago
(17-Jul-2023)
0/2 (0%)
$3.08 (334.78%)
Which analyst most recently updated their price target on NMRD (Nemaura Medical)?
Which analyst has the current lower performing score on NMRD (Nemaura Medical) with a proven track record?
Which analyst has the most public recommendations on NMRD (Nemaura Medical)?
Which analyst is the currently most bullish on NMRD (Nemaura Medical)?
Which analyst is the currently most reserved on NMRD (Nemaura Medical)?
